BioSpace News Archive

Feb. 25, 2020 13:30 UTC FDA Grants IND Approval to Promising Anti-Cancer Agent Veyonda ® Current IND for sarcoma paves the way for future INDs for late-stage prostate cancer SYDNEY--( BUSINESS WIRE )-- Noxopharm (ASX: NOX) announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for Veyonda ® for combination treatment with doxorubicin in patients with soft tissue sarcomas. “Based on preclinical an

Primavera Essentials is extremely excited to announce their line of high-quality CBD products and a brand that is invested in educating the discriminating buyer.

TUCSON, Ariz. , Feb. 25, 2020 /PRNewswire/ -- Emagine Solutions Technology, an award-winning medical software device company located in Tucson , announced that it has received clearance from the U.S. Food & Drug Administration (“FDA”) to market its VistaScan mobile ultrasound platform. The VistaScan platform transforms a clinician’s cell phone or tablet into a port

TwinStrand Duplex Sequencing technology offers unprecedented accuracy of DNA analysis, which is available in easily adopted reagent kit and cloud-based software format that can be applied to broad applications across medicine and basic research.

LLS cautions consumers to be wary of short-term plans and urges state and federal policymakers to protect patients

ENGLEWOOD, Colo. , Feb. 25, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the U.S. Food and Drug Administration (“FDA”) granted 510(k) clearance for sa

Feb. 25, 2020 14:00 UTC Welldoc and Redox Partner to Optimize Provider Interaction with Chronic Disease Management Platform Partnership ensures bidirectional integration with EHRs and insights available at the point of care MADISON, Wis.--( BUSINESS WIRE )-- Welldoc , a leading digital health company revolutionizing chronic disease management, announced today its strategic partnership with Redox Inc. , the leading interoperability platform for healthcare data exchange.

Feb. 25, 2020 14:03 UTC Logix Smart™ COVID-19 Test CE Marked & Available in Europe Four Weeks After Project Initiation MADISON, Wis.--( BUSINESS WIRE )-- Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc. for the support Promega custom manufacturing provided in the rapid development and launch of the new Logix Smart™ COVID-19 Test. Co-Diagnostics yesterday afternoon announced its coronavirus test received CE mark approval and is now availabl

Feb. 25, 2020 16:09 UTC Shattuck Labs to Present at 40 th Annual Cowen Health Care Conference AUSTIN, Texas--( BUSINESS WIRE )-- Shattuck Labs, Inc. (“Shattuck”), a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC™) platform to develop a novel class of biologic medicines for the treatment of cancer and other diseases, today announced that Shattuck Labs’ Chief Executive Officer, Taylor Schreiber, M.D., Ph.D., will present at the 40th

Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $850K from the National Science Foundation (NSF) to advance our understanding of how fungi like powdery mildew infect plants including food source crops, and how plants fight back.